Fluocortolone
![]() | |
Clinical data | |
---|---|
Other names | (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one |
Routes of administration | Ointment, suppositories |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.284 |
Chemical and physical data | |
Formula | C22H29FO4 |
Molar mass | 376.468 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Fluocortolone is a glucocorticoid[1] used in the treatment of several conditions, including hemorrhoids.
It is similar to fluocortin, but with one less keto group.
See also
[edit]References
[edit]- ^ Munro DD, Wilson HT, Rhodes EL (November 1967). "Comparison of betamethasone 17-valerate ointment with fluocortolone and fluocortolone caproate ointment". British Medical Journal. 4 (5574): 275–6. doi:10.1136/bmj.4.5574.275. PMC 1748932. PMID 6054003.